Found: 14
Select item for more details and to access through your institution.
Triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY phase 3 trials with alirocumab.
- Published in:
- European Journal of Preventive Cardiology, 2020, v. 27, n. 15, p. 1663, doi. 10.1177/2047487320905185
- By:
- Publication type:
- Article
Focus on atherosclerosis and lipids.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Replacing physical with virtual genetic tests: The importance of conscious methodological decisions.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Triglyceride-containing lipoprotein sub-fractions and risk of coronary heart disease and stroke: A prospective analysis in 11,560 adults.
- Published in:
- European Journal of Preventive Cardiology, 2020, v. 27, n. 15, p. 1617, doi. 10.1177/2047487319899621
- By:
- Publication type:
- Article
Non-HDL cholesterol series: PCSK9 inhibitor new season!
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Lower diabetes rate in patients with familial hypercholesterolaemia: What is the link?
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Free cholesterol transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis underlies the U-shape relationship between HDL-cholesterol and cardiovascular disease.
- Published in:
- European Journal of Preventive Cardiology, 2020, v. 27, n. 15, p. 1606, doi. 10.1177/2047487319894114
- By:
- Publication type:
- Article
Behavioural cardiovascular risk factors and prevalence of diabetes in subjects with familial hypercholesterolaemia.
- Published in:
- European Journal of Preventive Cardiology, 2020, v. 27, n. 15, p. 1649, doi. 10.1177/2047487319896138
- By:
- Publication type:
- Article
Virtual genetic diagnosis for familial hypercholesterolemia powered by machine learning.
- Published in:
- European Journal of Preventive Cardiology, 2020, v. 27, n. 15, p. 1639, doi. 10.1177/2047487319898951
- By:
- Publication type:
- Article
Evaluating statin effect on LDL-cholesterol: when predicted is not measured.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Recent advances in synthetic pharmacotherapies for dyslipidaemias.
- Published in:
- European Journal of Preventive Cardiology, 2020, v. 27, n. 15, p. 1576, doi. 10.1177/2047487319845314
- By:
- Publication type:
- Article
Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study.
- Published in:
- European Journal of Preventive Cardiology, 2020, v. 27, n. 15, p. 1597, doi. 10.1177/2047487319862401
- By:
- Publication type:
- Article
Percentage low-density lipoprotein-cholesterol response to a given statin dose is not fixed across the pre-treatment range: Real world evidence from clinical practice: Data from the ESC-EORP EUROASPIRE V Study.
- Published in:
- European Journal of Preventive Cardiology, 2020, v. 27, n. 15, p. 1630, doi. 10.1177/2047487319874898
- By:
- Publication type:
- Article
Efficacy of lipid-lowering therapy beyond statins to prevent cardiovascular events: a meta-analysis.
- Published in:
- European Journal of Preventive Cardiology, 2020, v. 27, n. 15, p. 1675, doi. 10.1177/2047487319866992
- By:
- Publication type:
- Article